Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study
São Paulo med. j
;
119(4): 135-137, July 2001.
Artículo
en Inglés
| LILACS
| ID: lil-302318
ABSTRACT
CONTEXT Despite the recent improvements in performing radical retropubic prostatectomy that have led to a considerable decrease in the complication rate, erectile dysfunction still represents a major problem. Moreover, less invasive treatment options that are emerging for erectile dysfunction have not shown satisfactory results in managing these patients. OBJECTIVE:
To study the efficacy and side effects of self-injection therapy in the treatment of men who had become impotent after undergoing radical prostatectomy due to prostate cancer, over a study period of 96 months.DESIGN:
Observational study.SETTING:
University Referral Center.PARTICIPANTS:
168 patients with erectile dysfunction, aged 43 to 78 years old, who underwent radical retropubic prostatectomy due to localized prostate cancer. PROCEDURES The patients were treated with self-injection therapy using papaverine, phentolamine and prostaglandin E1, at home.RESULTS:
This study showed an acceptable 94.6 percent success rate, with no life-threatening complications. In addition to this, our series presented a 13.1 percent cure rate with this therapy.CONCLUSION:
Self-injection therapy with papaverine, phentolamine and prostaglandin E1 is effective and safe in the treatment of erectile dysfunction after radical prostatectomy
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Prostatectomía
/
Vasodilatadores
/
Disfunción Eréctil
Tipo de estudio:
Estudio observacional
Límite:
Adulto
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
São Paulo med. j
Asunto de la revista:
Cirurgia Geral
/
Cincia
/
Ginecologia
/
Medicina
/
Medicina Interna
/
Obstetr¡cia
/
Pediatria
/
Sa£de Mental
/
Sa£de P£blica
Año:
2001
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Universidade Federal de Säo Paulo/BR
Similares
MEDLINE
...
LILACS
LIS